Sign in

CIK 0001396814

  • Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
510619477
Phone
+1 650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
  1. 4 Option exercise CEO and Chairman acquired 15,000 shares (option exercise)
  2. 4 Option exercise Chief Medical Officer acquired 10,000 shares (option exercise)
  3. 4 Grant or award Chief Medical Officer acquired 5,000 shares (grant or award)
  4. 4 Grant or award Chief Clinical Officer acquired 5,000 shares (grant or award)
  5. 4 Open-market sale Vice President, Finance sold 2,500 shares at an average $60.85 ($152,121)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale President, Rest of World sold 421 shares at $59.76 ($25,159)
  8. 4 Grant or award Chief Customer Officer acquired 6,000 shares (grant or award)
  9. 4 Grant or award Director acquired 1,066 shares (grant or award)
  10. 4 Grant or award President, Rest of World acquired 7,000 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 6,000 shares (grant or award)
  12. 4 Open-market sale Vice President, Finance sold 2,003 shares at $59.85 ($119,880)
  13. 4 Grant or award CEO and Chairman acquired 17,800 shares (grant or award)
  14. 4 Open-market sale Chief Administrative Officer sold 5,689 shares at an average $59.60 ($339,063)
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 11 of 35 · 695 filings